Determinants of lipid goal achievement in patients on extended-release nicotinic acid/laropiprant in primary care clinical practice

By Dänschel Wilfried   Steinhagen-Thiessen Elisabeth   Buffleben Claudia   Pittrow David   Hildemann Steven K.  

Current Medical Research and Opinion, Vol. 29, Iss. 1, 2013-01 ,pp. : 33-40

Informa Healthcare

Access to resources Recommend Favorite

Use of extended-release niacin in clinical practice

By Suryadevara Ramya S   Karas Richard H   Kuvin Jeffrey T  

Future Lipidology, Vol. 3, Iss. 1, 2008-02 ,pp. : 9-16

Future Medicine

Access to resources Recommend Favorite

A comparison of the pharmacokinetics of two different formulations of extended-release niacin

By Lauring B.   Rosko K.   Luo W.-L.   Wenning L.   Kissling J.   Roupe K.   Paolini J. F.   Wagner J.   Lai E.  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 15-22

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of extended-release fluvastatin in Turkish patients with hypercholesterolaemia: TULIPS (Turkish Lipid Study)

By İlerigelen B.   Üresin Y.   Şan M.   Kültürsay H.   Güneri S.   Serdar O. A.   Güleç S.   Pençedemir H.    

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1093-1102

Informa Healthcare

Access to resources Recommend Favorite

The effect of 24 months of combination statin and extended-release niacin on carotid intima–media thickness: ARBITER 3

By Taylor Allen J.   Lee Hyun J.   Sullenberger Lance E.  

Current Medical Research and Opinion, Vol. 22, Iss. 11, 2006-11 ,pp. : 2243-2250

Informa Healthcare

Access to resources Recommend Favorite